Gastric Cancer, Adenocarcinoma
1 competing product in clinical development for Gastric Cancer, Adenocarcinoma.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab deruxtecan + Ramucirumab + Paclitaxel | Daiichi Sankyo | Phase 3 | Active | 44 |